CN Patent

CN101068534B — 包括左乙拉西坦的药物组合物及其制备方法

Assigned to Shenji Pharmaceutical Hong Kong Co ltd · Expires 2011-09-07 · 15y expired

What this patent protects

本发明涉及一种药物组合物，包括作为活性成分的左乙拉西坦和相对于药物组合物的总重量的2.0至9.0％重量的崩解剂、0.0至3.0％重量的助流剂、0.5至6.0％重量的粘合剂、和0.0至1.0％重量的润滑剂，及其制备方法。

USPTO Abstract

本发明涉及一种药物组合物，包括作为活性成分的左乙拉西坦和相对于药物组合物的总重量的2.0至9.0％重量的崩解剂、0.0至3.0％重量的助流剂、0.5至6.0％重量的粘合剂、和0.0至1.0％重量的润滑剂，及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101068534B
Jurisdiction
CN
Classification
—
Expires
2011-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Shenji Pharmaceutical Hong Kong Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.